{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:02:35Z","timestamp":1784592155386,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":78,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Research Foundation of Korea (NRF) grant funded by the Korea government","award":["RS-2022-NR069128"],"award-info":[{"award-number":["RS-2022-NR069128"]}]},{"name":"National Research Foundation of Korea (NRF) grant funded by the Korea government","award":["RS-2021-NR062179"],"award-info":[{"award-number":["RS-2021-NR062179"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51493-z","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T15:38:16Z","timestamp":1777909096000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pathology-guided enrichment of targetable gene rearrangements in BRAF wild-type papillary thyroid carcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Meihua","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae A","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ji","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Mi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Yon","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Yong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Eun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Gu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"51493_CR1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","volume":"159","author":"N Agrawal","year":"2014","unstructured":"Agrawal, N. et al. Integrated genomic characterization of papillary thyroid carcinoma. Cell 159, 676\u2013690. https:\/\/doi.org\/10.1016\/j.cell.2014.09.050 (2014).","journal-title":"Cell"},{"key":"51493_CR2","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3803\/EnM.2015.30.3.252","volume":"30","author":"YS Song","year":"2015","unstructured":"Song, Y. S., Lim, J. A. & Park, Y. J. Mutation Profile of Well-Differentiated Thyroid Cancer in Asians. Endocrinol. metabolism (Seoul Korea). 30, 252\u2013262. https:\/\/doi.org\/10.3803\/EnM.2015.30.3.252 (2015).","journal-title":"Endocrinol. metabolism (Seoul Korea)"},{"issue":"Suppl 2","key":"51493_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/modpathol.2008.10","volume":"21","author":"YE Nikiforov","year":"2008","unstructured":"Nikiforov, Y. E. Thyroid carcinoma: molecular pathways and therapeutic targets. Mod. Pathol. 21 (Suppl 2), 37\u201343. https:\/\/doi.org\/10.1038\/modpathol.2008.10 (2008).","journal-title":"Mod. Pathol."},{"key":"51493_CR4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1089\/thy.2017.0318","volume":"28","author":"VD Yakushina","year":"2018","unstructured":"Yakushina, V. D., Lerner, L. V. & Lavrov, A. V. Gene Fusions in Thyroid Cancer. Thyroid 28, 158\u2013167. https:\/\/doi.org\/10.1089\/thy.2017.0318 (2018).","journal-title":"Thyroid"},{"key":"51493_CR5","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.1038\/ncomms5846","volume":"5","author":"N Stransky","year":"2014","unstructured":"Stransky, N., Cerami, E., Schalm, S., Kim, J. L. & Lengauer, C. The landscape of kinase fusions in cancer. Nat. Commun. 5, 4846. https:\/\/doi.org\/10.1038\/ncomms5846 (2014).","journal-title":"Nat. Commun."},{"key":"51493_CR6","doi-asserted-by":"publisher","first-page":"e000023","DOI":"10.1136\/esmoopen-2015-000023","volume":"1","author":"A Amatu","year":"2016","unstructured":"Amatu, A., Sartore-Bianchi, A. & Siena, S. NTRK gene fusions as novel targets of cancer therapy across multiple tumour types. ESMO Open. 1, e000023. https:\/\/doi.org\/10.1136\/esmoopen-2015-000023 (2016).","journal-title":"ESMO Open."},{"key":"51493_CR7","first-page":"2459","volume":"11","author":"S Klugbauer","year":"1995","unstructured":"Klugbauer, S., Lengfelder, E., Demidchik, E. P. & Rabes, H. M. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene 11, 2459\u20132467 (1995).","journal-title":"Oncogene"},{"key":"51493_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/(sici)1097-0215(19990105)80:1<32::aid-ijc7>3.0.co;2-l","volume":"80","author":"J Smida","year":"1999","unstructured":"Smida, J. et al. Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus. Int. J. Cancer. 80, 32\u201338. https:\/\/doi.org\/10.1002\/(sici)1097-0215(19990105)80:1%3C32::aid-ijc7%3E3.0.co;2-l (1999).","journal-title":"Int. J. Cancer"},{"key":"51493_CR9","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1210\/en.2006-0921","volume":"148","author":"R Ciampi","year":"2007","unstructured":"Ciampi, R. & Nikiforov, Y. E. RET\/PTC rearrangements and BRAF mutations in thyroid tumorigenesis. Endocrinology 148, 936\u2013941. https:\/\/doi.org\/10.1210\/en.2006-0921 (2007).","journal-title":"Endocrinology"},{"key":"51493_CR10","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1056\/NEJMoa1714448","volume":"378","author":"A Drilon","year":"2018","unstructured":"Drilon, A. et al. Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children. N Engl. J. Med. 378, 731\u2013739. https:\/\/doi.org\/10.1056\/NEJMoa1714448 (2018).","journal-title":"N Engl. J. Med."},{"key":"51493_CR11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/s1470-2045(19)30856-3","volume":"21","author":"DS Hong","year":"2020","unstructured":"Hong, D. S. et al. Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1\/2 clinical trials. Lancet Oncol. 21, 531\u2013540. https:\/\/doi.org\/10.1016\/s1470-2045(19)30856-3 (2020).","journal-title":"Lancet Oncol."},{"key":"51493_CR12","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1530\/eje-21-1259","volume":"186","author":"SG Waguespack","year":"2022","unstructured":"Waguespack, S. G. et al. Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma. Eur. J. Endocrinol. 186, 631\u2013643. https:\/\/doi.org\/10.1530\/eje-21-1259 (2022).","journal-title":"Eur. J. Endocrinol."},{"key":"51493_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/s1470-2045(19)30691-6","volume":"21","author":"RC Doebele","year":"2020","unstructured":"Doebele, R. C. et al. Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1\u20132 trials. Lancet Oncol. 21, 271\u2013282. https:\/\/doi.org\/10.1016\/s1470-2045(19)30691-6 (2020).","journal-title":"Lancet Oncol."},{"key":"51493_CR14","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/NEJMoa2005651","volume":"383","author":"LJ Wirth","year":"2020","unstructured":"Wirth, L. J. et al. Efficacy of Selpercatinib in RET-Altered Thyroid Cancers. N Engl. J. Med. 383, 825\u2013835. https:\/\/doi.org\/10.1056\/NEJMoa2005651 (2020).","journal-title":"N Engl. J. Med."},{"key":"51493_CR15","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","volume":"363","author":"EL Kwak","year":"2010","unstructured":"Kwak, E. L. et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl. J. Med. 363, 1693\u20131703. https:\/\/doi.org\/10.1056\/NEJMoa1006448 (2010).","journal-title":"N Engl. J. Med."},{"key":"51493_CR16","doi-asserted-by":"publisher","first-page":"e1005467","DOI":"10.1371\/journal.pgen.1005467","volume":"11","author":"JH Ji","year":"2015","unstructured":"Ji, J. H. et al. Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer. PLoS Genet. 11, e1005467. https:\/\/doi.org\/10.1371\/journal.pgen.1005467 (2015).","journal-title":"PLoS Genet."},{"key":"51493_CR17","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1089\/thy.2022.0533","volume":"33","author":"AV 17 Nikitski","year":"2023","unstructured":"17 Nikitski, A. V., Condello, V., Divakaran, S. S. & Nikiforov, Y. E. Inhibition of ALK-Signaling Overcomes STRN-ALK-Induced Downregulation of the Sodium Iodine Symporter and Restores Radioiodine Uptake in Thyroid Cells. Thyroid 33, 464\u2013473. https:\/\/doi.org\/10.1089\/thy.2022.0533 (2023).","journal-title":"Thyroid"},{"key":"51493_CR18","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: thyroid carcinoma. Plymouth Meeting: NCCN Guideline Version 1.2023. In."},{"key":"51493_CR19","doi-asserted-by":"publisher","first-page":"e1006239","DOI":"10.1371\/journal.pgen.1006239","volume":"12","author":"SK Yoo","year":"2016","unstructured":"Yoo, S. K. et al. Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers. PLoS Genet. 12, e1006239. https:\/\/doi.org\/10.1371\/journal.pgen.1006239 (2016).","journal-title":"PLoS Genet."},{"key":"51493_CR20","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1038\/s41379-020-0638-5","volume":"33","author":"YH Chu","year":"2020","unstructured":"Chu, Y. H. et al. Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization. Mod. Pathol. 33, 2458\u20132472. https:\/\/doi.org\/10.1038\/s41379-020-0638-5 (2020).","journal-title":"Mod. Pathol."},{"key":"51493_CR21","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1038\/s41379-020-0574-4","volume":"33","author":"YH Chu","year":"2020","unstructured":"Chu, Y. H. et al. Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC). Mod. Pathol. 33, 2186\u20132197. https:\/\/doi.org\/10.1038\/s41379-020-0574-4 (2020).","journal-title":"Mod. Pathol."},{"key":"51493_CR22","doi-asserted-by":"publisher","unstructured":"Pekova, B. et al. NTRK Fusion Genes in Thyroid Carcinomas: Clinicopathological Characteristics and Their Impacts on Prognosis. Cancers (Basel). 13. https:\/\/doi.org\/10.3390\/cancers13081932 (2021).","DOI":"10.3390\/cancers13081932"},{"key":"51493_CR23","doi-asserted-by":"publisher","first-page":"103957","DOI":"10.1016\/j.critrevonc.2023.103957","volume":"184","author":"Y Ma","year":"2023","unstructured":"Ma, Y. et al. NTRK fusions in thyroid cancer: Pathology and clinical aspects. Crit. Rev. Oncol. Hematol. 184, 103957. https:\/\/doi.org\/10.1016\/j.critrevonc.2023.103957 (2023).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"51493_CR24","first-page":"1093","volume":"6","author":"HM Rabes","year":"2000","unstructured":"Rabes, H. M. et al. Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications. Clin. Cancer Res. 6, 1093\u20131103 (2000).","journal-title":"Clin. Cancer Res."},{"key":"51493_CR25","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1089\/thy.2016.0101","volume":"26","author":"LL Ritterhouse","year":"2016","unstructured":"Ritterhouse, L. L. et al. ROS1 Rearrangement in Thyroid Cancer. Thyroid 26, 794\u2013797. https:\/\/doi.org\/10.1089\/thy.2016.0101 (2016).","journal-title":"Thyroid"},{"key":"51493_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.humpath.2020.09.004","volume":"106","author":"Y Nozaki","year":"2020","unstructured":"Nozaki, Y. et al. Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas. Hum. Pathol. 106, 82\u201392. https:\/\/doi.org\/10.1016\/j.humpath.2020.09.004 (2020).","journal-title":"Hum. Pathol."},{"key":"51493_CR27","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1089\/thy.2019.0802","volume":"30","author":"B Pekova","year":"2020","unstructured":"Pekova, B. et al. RET, NTRK, ALK, BRAF, and MET Fusions in a Large Cohort of Pediatric Papillary Thyroid Carcinomas. Thyroid 30, 1771\u20131780. https:\/\/doi.org\/10.1089\/thy.2019.0802 (2020).","journal-title":"Thyroid"},{"key":"51493_CR28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.mpdhp.2021.03.003","volume":"27","author":"YH Chu","year":"2021","unstructured":"Chu, Y. H. & Sadow, P. M. Kinase fusion-related thyroid carcinomas: distinct pathologic entities with evolving diagnostic implications. Diagn. Histopathol (Oxf). 27, 252\u2013262. https:\/\/doi.org\/10.1016\/j.mpdhp.2021.03.003 (2021).","journal-title":"Diagn. Histopathol (Oxf)"},{"key":"51493_CR29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41379-019-0324-7","volume":"33","author":"JP Solomon","year":"2020","unstructured":"Solomon, J. P. et al. NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls. Mod. Pathol. 33, 38\u201346. https:\/\/doi.org\/10.1038\/s41379-019-0324-7 (2020).","journal-title":"Mod. Pathol."},{"key":"51493_CR30","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1158\/0008-5472.Can-19-0372","volume":"79","author":"JP Solomon","year":"2019","unstructured":"Solomon, J. P. & Hechtman, J. F. Detection of NTRK Fusions: Merits and Limitations of Current Diagnostic Platforms. Cancer Res. 79, 3163\u20133168. https:\/\/doi.org\/10.1158\/0008-5472.Can-19-0372 (2019).","journal-title":"Cancer Res."},{"key":"51493_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1530\/erc-14-0467","volume":"22","author":"G Park","year":"2015","unstructured":"Park, G. et al. Standard immunohistochemistry efficiently screens for anaplastic lymphoma kinase rearrangements in differentiated thyroid cancer. Endocr. Relat. Cancer. 22, 55\u201363. https:\/\/doi.org\/10.1530\/erc-14-0467 (2015).","journal-title":"Endocr. Relat. Cancer"},{"key":"51493_CR32","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/pas.0000000000000368","volume":"39","author":"A Chou","year":"2015","unstructured":"Chou, A. et al. A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma. Am. J. Surg. Pathol. 39, 652\u2013659. https:\/\/doi.org\/10.1097\/pas.0000000000000368 (2015).","journal-title":"Am. J. Surg. Pathol."},{"key":"51493_CR33","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1158\/1078-0432.Ccr-20-3208","volume":"27","author":"SR Yang","year":"2021","unstructured":"Yang, S. R. et al. A Performance Comparison of Commonly Used Assays to Detect RET Fusions. Clin. Cancer Res. 27, 1316\u20131328. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-20-3208 (2021).","journal-title":"Clin. Cancer Res."},{"key":"51493_CR34","doi-asserted-by":"publisher","first-page":"103957","DOI":"10.1016\/j.critrevonc.2023.103957","volume":"184","author":"Y Ma","year":"2023","unstructured":"Ma, Y. et al. NTRK fusions in thyroid cancer: Pathology and clinical aspects. Crit. Rev. Oncol. Hematol. 184, 103957. https:\/\/doi.org\/10.1016\/j.critrevonc.2023.103957 (2023).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"51493_CR35","doi-asserted-by":"publisher","unstructured":"Ko, G. et al. KoNA: Korean Nucleotide Archive as A New Data Repository for Nucleotide Sequence Data. Genomics Proteom. Bioinf. 22 https:\/\/doi.org\/10.1093\/gpbjnl\/qzae017 (2024).","DOI":"10.1093\/gpbjnl\/qzae017"},{"key":"51493_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41379-018-0118-3","volume":"32","author":"Z Gatalica","year":"2019","unstructured":"Gatalica, Z., Xiu, J., Swensen, J. & Vranic, S. Molecular characterization of cancers with NTRK gene fusions. Mod. Pathol. 32, 147\u2013153. https:\/\/doi.org\/10.1038\/s41379-018-0118-3 (2019).","journal-title":"Mod. Pathol."},{"key":"51493_CR37","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1001\/jamaoncol.2023.1379","volume":"9","author":"R Haddad","year":"2023","unstructured":"Haddad, R. et al. Diagnosis and Management of Tropomyosin Receptor Kinase Fusion-Positive Thyroid Carcinomas: A Review. JAMA Oncol. 9, 1132\u20131141. https:\/\/doi.org\/10.1001\/jamaoncol.2023.1379 (2023).","journal-title":"JAMA Oncol."},{"key":"51493_CR38","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1159\/000333453","volume":"55","author":"GD Smith","year":"2011","unstructured":"Smith, G. D. et al. Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens. Acta Cytol. 55, 576\u2013583. https:\/\/doi.org\/10.1159\/000333453 (2011).","journal-title":"Acta Cytol."},{"key":"51493_CR39","doi-asserted-by":"publisher","first-page":"E1130","DOI":"10.1210\/jc.2013-4048","volume":"99","author":"X Liu","year":"2014","unstructured":"Liu, X. et al. TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer. J. Clin. Endocrinol. Metab. 99, E1130\u20131136. https:\/\/doi.org\/10.1210\/jc.2013-4048 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"51493_CR40","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1200\/jco.2014.55.5094","volume":"32","author":"M Xing","year":"2014","unstructured":"Xing, M. et al. BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. J. Clin. Oncol. 32, 2718\u20132726. https:\/\/doi.org\/10.1200\/jco.2014.55.5094 (2014).","journal-title":"J. Clin. Oncol."},{"key":"51493_CR41","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1056\/nejm199801293380506","volume":"338","author":"MJ Schlumberger","year":"1998","unstructured":"Schlumberger, M. J. Papillary and follicular thyroid carcinoma. N Engl. J. Med. 338, 297\u2013306. https:\/\/doi.org\/10.1056\/nejm199801293380506 (1998).","journal-title":"N Engl. J. Med."},{"key":"51493_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(19981215)83:12%3C2638::aid-cncr31%3E3.0.co;2-1","author":"SA Hundahl","year":"1998","unstructured":"Hundahl, S. A., Fleming, I. D., Fremgen, A. M., Menck, H. R. A. & .S. 1985\u20131995 [see commetns]. Cancer 83, 2638\u20132648. https:\/\/doi.org\/10.1002\/(sici)1097-0142(19981215)83:12%3C2638::aid-cncr31%3E3.0.co;2-1 (1998). National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U."},{"key":"51493_CR43","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/jnci\/djx209","volume":"110","author":"AA Efanov","year":"2018","unstructured":"Efanov, A. A. et al. Investigation of the Relationship Between Radiation Dose and Gene Mutations and Fusions in Post-Chernobyl Thyroid Cancer. J. Natl. Cancer Inst. 110, 371\u2013378. https:\/\/doi.org\/10.1093\/jnci\/djx209 (2018).","journal-title":"J. Natl. Cancer Inst."},{"key":"51493_CR44","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1089\/thy.2014.0067","volume":"24","author":"MJ Armstrong","year":"2014","unstructured":"Armstrong, M. J. et al. PAX8\/PPAR\u03b3 rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinoma. Thyroid 24, 1369\u20131374. https:\/\/doi.org\/10.1089\/thy.2014.0067 (2014).","journal-title":"Thyroid"},{"key":"51493_CR45","doi-asserted-by":"publisher","first-page":"100222","DOI":"10.1016\/j.modpat.2023.100222","volume":"36","author":"JF Hang","year":"2023","unstructured":"Hang, J. F. & Lee, Y. C. How Sensitive is Pan-TRK Immunohistochemistry for Detecting NTRK Fusions in Papillary Thyroid Carcinoma? Mod. Pathol. 36, 100222. https:\/\/doi.org\/10.1016\/j.modpat.2023.100222 (2023).","journal-title":"Mod. Pathol."},{"key":"51493_CR46","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s12022-020-09648-9","volume":"31","author":"YC Lee","year":"2020","unstructured":"Lee, Y. C. et al. Detection of NTRK1\/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing. Endocr. Pathol. 31, 348\u2013358. https:\/\/doi.org\/10.1007\/s12022-020-09648-9 (2020).","journal-title":"Endocr. Pathol."},{"key":"51493_CR47","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1530\/eje-20-1345","volume":"184","author":"Y Kong","year":"2021","unstructured":"Kong, Y. et al. NTRK fusion analysis reveals enrichment in Middle Eastern BRAF wild-type PTC. Eur. J. Endocrinol. 184, 503\u2013511. https:\/\/doi.org\/10.1530\/eje-20-1345 (2021).","journal-title":"Eur. J. Endocrinol."},{"key":"51493_CR48","doi-asserted-by":"publisher","unstructured":"Macerola, E. et al. Limited Accuracy of Pan-Trk Immunohistochemistry Screening for NTRK Rearrangements in Follicular-Derived Thyroid Carcinoma. Int. J. Mol. Sci. 23 https:\/\/doi.org\/10.3390\/ijms23137470 (2022).","DOI":"10.3390\/ijms23137470"},{"key":"51493_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12022-025-09852-5","volume":"36","author":"H Lee","year":"2025","unstructured":"Lee, H. et al. Refining NTRK Fusion Detection in Papillary Thyroid Carcinoma Through Pan-TRK Immunohistochemistry and Histopathologic Features. Endocr. Pathol. 36, 7. https:\/\/doi.org\/10.1007\/s12022-025-09852-5 (2025).","journal-title":"Endocr. Pathol."},{"key":"51493_CR50","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1172\/jci85271","volume":"126","author":"I Landa","year":"2016","unstructured":"Landa, I. et al. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J. Clin. Invest. 126, 1052\u20131066. https:\/\/doi.org\/10.1172\/jci85271 (2016).","journal-title":"J. Clin. Invest."},{"key":"51493_CR51","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1530\/eje-18-0653","volume":"180","author":"K van der Tuin","year":"2019","unstructured":"van der Tuin, K. et al. Targetable gene fusions identified in radioactive iodine refractory advanced thyroid carcinoma. Eur. J. Endocrinol. 180, 235\u2013241. https:\/\/doi.org\/10.1530\/eje-18-0653 (2019).","journal-title":"Eur. J. Endocrinol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51493-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51493-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51493-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:05:51Z","timestamp":1784588751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51493-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51493"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51493-z","relation":{"references":[{"id-type":"doi","id":"10.1002\/(sici)1097-0142(19981215)83:12<2638::aid-cncr31>3.0.co;2-1","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"22762"}}